1. Home
  2. BCML vs GOSS Comparison

BCML vs GOSS Comparison

Compare BCML & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayCom Corp

BCML

BayCom Corp

HOLD

Current Price

$30.37

Market Cap

348.1M

Sector

Finance

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.23

Market Cap

796.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCML
GOSS
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
348.1M
796.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BCML
GOSS
Price
$30.37
$3.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$32.00
$8.60
AVG Volume (30 Days)
22.6K
4.3M
Earning Date
01-22-2026
11-05-2025
Dividend Yield
3.95%
N/A
EPS Growth
N/A
N/A
EPS
2.10
N/A
Revenue
$94,896,000.00
$44,051,000.00
Revenue This Year
$0.51
N/A
Revenue Next Year
$10.33
$6.41
P/E Ratio
$14.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.22
$0.76
52 Week High
$33.15
$3.87

Technical Indicators

Market Signals
Indicator
BCML
GOSS
Relative Strength Index (RSI) 48.92 46.76
Support Level $29.41 $3.21
Resistance Level $33.15 $3.87
Average True Range (ATR) 1.08 0.29
MACD -0.23 -0.06
Stochastic Oscillator 43.57 3.42

Price Performance

Historical Comparison
BCML
GOSS

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: